PUBLICATION

Global Business Reports

AUTHORS

Sorina Dumitru, Lindsay Davis, Sarah Crompton Donnelly

China Pharmaceuticals 2018

June 13, 2018

Long dismissed as a “me too” market, China’s pharmaceutical industry has undergone extraordinary transformation in recent years. Responding to the needs of its ever-growing and rapidly evolving population, the central government has led a concerted effort to shift the industry’s focus towards innovation by injecting significant capital into the market, enticing talent from overseas to return, and introducing a series of regulatory reforms geared towards driving industry consolidation. Following suit, the private sector has also begun to invest heavily in the life sciences, supporting a small but strengthening biotech sector that will begin to see results in just a few more years. To meet burgeoning demand for cutting edge technologies, the services sector is also bolstering its capacity and new players are taking advantage of the opportunities where gaps remain. As 2020 approaches, China’s rapid ascent to the forefront of the global stage may soon allow the country to overtake the United States as the number one pharmaceutical industry worldwide. 

RELATED INTERVIEWS MORE INTERVIEWS

Powered by its XmAb antibody engineering platform, Xencor is developing a broad pipeline of drug candidates that are optimized to treat autoimmune disorders, cancer, asthma and allergic diseases.
Piramal Pharma updates GBR in its recent developments and prospects.
Tango Therapeutics is targeting unaddressed disease mechanisms in cancer to develop transformational new drugs for patients.
Founded in 2008, Eiger BioPharmaceuticals is a late-stage biopharmaceutical company focused on developing and commercializing targeted therapies for rare diseases.

RECENT PUBLICATIONS

MACIG 2024 - Mining in Africa Country Investment Guide

A decade after launching the first MACIG, the 2024 edition still spans thousands of kilometers, over 150 interviews, and a dozen country profiles to paint the most comprehensive picture of a complex and fundamental continent for global mining. The extraordinary, unprecedented demand for the continent’s resources is currently balanced by the global landscape of uncertainty and price volatility. The latter keeps deterring investor appetite in projects sitting in nations with little political stability and affected by infrastructure, energy, and security woes. As these opposing forces continue to unfold, the fate of the African mining sector teeters on the precipice of either a generational opportunity or missed potential.

MORE PREVIOUSLY PUBLISHED

MACIG

"We believe technology should enhance, not replace, the role of geologists in exploration."

SUBSCRIBE TO OUR NEWSLETTER